The Nobel Price in Physiology or Medicine 2019 rewards discoveries that form the basis for our drug development projects

2019-10-07

The Nobel Prize in Physiology or Medicine 2019 rewards discoveries of how cells sense and adapt to oxygen supply. The award-winning research has thus laid the foundation for drug development against both inflammation and cancer. The Nobel Prize specifically addresses the interest in proteins regulated by the oxygen-sensitive factor HIF-1alpha, including the fractalkine receptor CX3CR1 and the enzyme PFKFB3, both of which form the basis of Kancera’s ongoing drug development.